CIO Influence
CIO Influence News Cloud

LYSARC Partners with Veeva to Accelerate Innovation for Lymphoma Treatments

LYSARC Partners with Veeva to Accelerate Innovation for Lymphoma Treatments
European research association establishing technology foundation for greater efficiency and speed across research projects

Veeva Systems announced that the Lymphoma Academic Research Organization (LYSARC) selected Veeva Development Cloud to improve operational efficiency across its lymphoma therapy research. LYSARC will use applications in Vault Clinical, Vault Quality, and Vault Safety suites to build a robust, connected technology foundation that enables faster execution, higher quality data, and better trial oversight.

“Partnering with Veeva will accelerate our digital transformation for greater scalability and speed in our pursuit to develop innovative lymphoma therapies or improve current therapies,” said Franck Morschhauser, president of LYSARC. “Using Veeva Development Cloud gives us a single connected platform that can free our staff from time-consuming tasks and allow them to focus on what drives us every day: scientific excellence for the benefit of lymphoma patients.”

Top iTechnology IT and DevOps News: GDPR SoftwareReviews Announces 2022’s Best Enterprise Architecture Software

The largest European academic organization devoted to lymphoma clinical research, LYSARC recruits more than 750 patients every year across BelgiumFrance, and Portugal. To expand its reach, the organization is collaborating with other academic groups in Europe or abroad, in partnership with pharma companies, and needed technology that can scale with its growth.

Veeva Development Cloud will bring together clinical, quality, and safety operations for end-to-end business processes and execution. With a digital and unified systems landscape, LYSARC can improve the patient trial experience, ensure alignment with SOPs across stakeholders, and reduce the costs and lead times of clinical trials.

“LYSARC is fully invested in empowering its teams with advanced technologies to evolve how they work together in a complex environment,” said Jim Reilly, vice president of Vault R&D and Quality at Veeva Systems. “We’re proud to work with an organization dedicated to innovation, and we look forward to supporting their development of new lymphoma research and therapies.”

LYSARC, the operational structure of the cooperative group LYSA, is standardizing clinical processes with Vault CDMS, Vault CTMS, Vault eTMF, Vault Study Start-up, and Vault Payments, streamlining quality processes with Vault QMS, Vault QualityDocs, and Vault Training, and mitigating risk with Vault Safety. The organization will also encourage its network of partners to adopt Veeva SiteVault Free to enable seamless information sharing with site investigators and sponsors.

Top iTechnology Security News: Reltime Defi Ecosystem Is Shaking Things Up With A Switch To Poa Based Blockchain Network

[To share your insights with us, please write to sghosh@martechseries.com]

 

Related posts

Netskope Sets New Industry Benchmarks for Cloud Security Performance; Announces Industry-First SLA to Address Encrypted Traffic Processing

CIO Influence News Desk

ETQ Builds Strong Momentum in Second Quarter as More Global Businesses Embrace Quality Management to Improve Business Outcomes

PR Newswire

Relativity’s Security Sandbox Podcast Joins the CyberWire Network

CIO Influence News Desk

Leave a Comment